- Home
- CLLS vs CLPT Comparison
CLLS vs CLPT Comparison
Compare CLLS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- CLPT
- Stock Information
- Founded
- CLLS 1999
- CLPT 1998
- Country
- CLLS France
- CLPT United States
- Employees
- CLLS N/A
- CLPT N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- CLLS Health Care
- CLPT Health Care
- Exchange
- CLLS Nasdaq
- CLPT Nasdaq
- Market Cap
- CLLS 299.0M
- CLPT 317.4M
- IPO Year
- CLLS 2007
- CLPT N/A
- Fundamental
- Price
- CLLS $2.85
- CLPT $10.70
- Analyst Decision
- CLLS Buy
- CLPT Strong Buy
- Analyst Count
- CLLS 1
- CLPT 3
- Target Price
- CLLS $4.00
- CLPT $27.67
- AVG Volume (30 Days)
- CLLS 199.3K
- CLPT 399.1K
- Earning Date
- CLLS 08-04-2025
- CLPT 08-12-2025
- Dividend Yield
- CLLS N/A
- CLPT N/A
- EPS Growth
- CLLS N/A
- CLPT N/A
- EPS
- CLLS N/A
- CLPT N/A
- Revenue
- CLLS $63,438,000.00
- CLPT $33,593,000.00
- Revenue This Year
- CLLS N/A
- CLPT $23.97
- Revenue Next Year
- CLLS $4.90
- CLPT $27.52
- P/E Ratio
- CLLS N/A
- CLPT N/A
- Revenue Growth
- CLLS 223.09
- CLPT 19.68
- 52 Week Low
- CLLS $1.10
- CLPT $9.76
- 52 Week High
- CLLS $3.24
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- CLLS 59.27
- CLPT 46.60
- Support Level
- CLLS $2.71
- CLPT $10.06
- Resistance Level
- CLLS $3.08
- CLPT $11.95
- Average True Range (ATR)
- CLLS 0.20
- CLPT 0.60
- MACD
- CLLS -0.03
- CLPT -0.02
- Stochastic Oscillator
- CLLS 61.67
- CLPT 36.22
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.